Sign in
4

Changes in Ownership

BIOLARGO, INC. Filed Acc 0001463205-10-000008

Options or other derivatives

  • Chief Financial Officer acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DARGAN CHARLES K · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-04-30 Grant or award : show line 1 in the form Option to Purchase Common Stock +30,000 $0.45 2020-04-30 30,000 426,000 D
Loading xslF345X03/primary_doc.xml…